Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
E.M. Ciruelos1, X. González-Farré2, A. Perelló3, E. Alba4, P. Palacios-Ozores5, J. Salvador-Bofil6, M. Merino7, P. Villagrasa8, P. Celiz8, T. Pascual8, A. Prat9, S. Pernas Simon10
Communication in congress
Results poster
ESMO BREAST
2020
